Literature DB >> 20021358

A structure-affinity and comparative molecular field analysis of sigma-2 (sigma2) receptor ligands.

Carmen Abate1, Philip Daniel Mosier, Francesco Berardi, Richard A Glennon.   

Abstract

Several sigma(1) receptor ligands with sub-nanomolar affinity and excellent selectivity have been reported, but relatively few sigma(2)-selective ligands are known. 1-Cyclohexyl-4-[3-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)propyl] piperazine (PB28; 1) has been reported by us as a high-affinity sigma(2) receptor ligand with significant sigma(2) selectivity, and several analogs of (1) now have been developed. Among these are the class of cyclohexylpiperazines that display a good compromise between affinity/activity and selectivity for sigma(2) receptors. Very little is currently known about the nature of sigma(2) receptors. In the absence of structure-based receptor information, we applied a comparative molecular field analysis (CoMFA) - a three-dimensional structure-activity relationship (3D-QSAR) method - to a set of cyclohexylpiperazine sigma(2) ligands to develop a predictive model that might provide information about the stereoelectronic nature of the receptor binding site. Two CoMFA models were generated from two different alignments: the first used an automated FlexS algorithm, and the second used a rationally-driven manual alignment. Significantly better predictivity was obtained with the manual alignment (TSET: q(2) = 0.73, r(2) = 0.95; PSET: r(2) = 0.55/0.73) than from the automated alignment (TSET: q(2) = 0.69, r(2) = 0.98; PSET: r(2) = 0.13/0.16). The resulting CoMFA maps account for observed structure-affinity relationships and suggest a possible anatomy for the sigma(2) receptor/cyclohexylpiperazine binding site.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20021358     DOI: 10.2174/1871524910909030246

Source DB:  PubMed          Journal:  Cent Nerv Syst Agents Med Chem        ISSN: 1871-5249


  12 in total

1.  Synthesis and in vitro biological evaluation of carbonyl group-containing analogues for σ1 receptors.

Authors:  Wei Wang; Jinquan Cui; Xiaoxia Lu; Prashanth K Padakanti; Jinbin Xu; Stanley M Parsons; Robert R Luedtke; Nigam P Rath; Zhude Tu
Journal:  J Med Chem       Date:  2011-07-20       Impact factor: 7.446

2.  Sigma receptors [σRs]: biology in normal and diseased states.

Authors:  Colin G Rousseaux; Stephanie F Greene
Journal:  J Recept Signal Transduct Res       Date:  2015-06-09       Impact factor: 2.092

3.  Electron-donating para-methoxy converts a benzamide-isoquinoline derivative into a highly Sigma-2 receptor selective ligand.

Authors:  Abdol R Hajipour; Lian-Wang Guo; Arindam Pal; Timur Mavlyutov; Arnold E Ruoho
Journal:  Bioorg Med Chem       Date:  2011-10-20       Impact factor: 3.641

4.  Multifunctional thiosemicarbazones and deconstructed analogues as a strategy to study the involvement of metal chelation, Sigma-2 (σ2) receptor and P-gp protein in the cytotoxic action: In vitro and in vivo activity in pancreatic tumors.

Authors:  Maria Laura Pati; Mauro Niso; Dirk Spitzer; Francesco Berardi; Marialessandra Contino; Chiara Riganti; William G Hawkins; Carmen Abate
Journal:  Eur J Med Chem       Date:  2017-12-08       Impact factor: 6.514

5.  Fluorescent derivatives of σ receptor ligand 1-cyclohexyl-4-[3-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)propyl]piperazine (PB28) as a tool for uptake and cellular localization studies in pancreatic tumor cells.

Authors:  Carmen Abate; John R Hornick; Dirk Spitzer; William G Hawkins; Mauro Niso; Roberto Perrone; Francesco Berardi
Journal:  J Med Chem       Date:  2011-07-20       Impact factor: 7.446

6.  The 2014 Philip S. Portoghese Medicinal Chemistry Lectureship: The "Phenylalkylaminome" with a Focus on Selected Drugs of Abuse.

Authors:  Richard A Glennon
Journal:  J Med Chem       Date:  2017-03-15       Impact factor: 7.446

7.  Ether modifications to 1-[2-(3,4-dimethoxyphenyl)ethyl]-4-(3-phenylpropyl)piperazine (SA4503): effects on binding affinity and selectivity for sigma receptors and monoamine transporters.

Authors:  Rong Xu; Sarah A Lord; Ryan M Peterson; Emily A Fergason-Cantrell; John R Lever; Susan Z Lever
Journal:  Bioorg Med Chem       Date:  2014-11-11       Impact factor: 3.641

8.  Chlorophenylpiperazine analogues as high affinity dopamine transporter ligands.

Authors:  William C Motel; Jason R Healy; Eddy Viard; Buddy Pouw; Kelly Martin; Rae R Matsumoto; Andrew Coop
Journal:  Bioorg Med Chem Lett       Date:  2013-10-15       Impact factor: 2.823

9.  Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms.

Authors:  David E Gordon; Joseph Hiatt; Mehdi Bouhaddou; Veronica V Rezelj; Svenja Ulferts; Hannes Braberg; Alexander S Jureka; Kirsten Obernier; Jeffrey Z Guo; Jyoti Batra; Robyn M Kaake; Andrew R Weckstein; Tristan W Owens; Meghna Gupta; Sergei Pourmal; Erron W Titus; Merve Cakir; Margaret Soucheray; Michael McGregor; Zeynep Cakir; Gwendolyn Jang; Matthew J O'Meara; Tia A Tummino; Ziyang Zhang; Helene Foussard; Ajda Rojc; Yuan Zhou; Dmitry Kuchenov; Ruth Hüttenhain; Jiewei Xu; Manon Eckhardt; Danielle L Swaney; Jacqueline M Fabius; Manisha Ummadi; Beril Tutuncuoglu; Ujjwal Rathore; Maya Modak; Paige Haas; Kelsey M Haas; Zun Zar Chi Naing; Ernst H Pulido; Ying Shi; Inigo Barrio-Hernandez; Danish Memon; Eirini Petsalaki; Alistair Dunham; Miguel Correa Marrero; David Burke; Cassandra Koh; Thomas Vallet; Jesus A Silvas; Caleigh M Azumaya; Christian Billesbølle; Axel F Brilot; Melody G Campbell; Amy Diallo; Miles Sasha Dickinson; Devan Diwanji; Nadia Herrera; Nick Hoppe; Huong T Kratochvil; Yanxin Liu; Gregory E Merz; Michelle Moritz; Henry C Nguyen; Carlos Nowotny; Cristina Puchades; Alexandrea N Rizo; Ursula Schulze-Gahmen; Amber M Smith; Ming Sun; Iris D Young; Jianhua Zhao; Daniel Asarnow; Justin Biel; Alisa Bowen; Julian R Braxton; Jen Chen; Cynthia M Chio; Un Seng Chio; Ishan Deshpande; Loan Doan; Bryan Faust; Sebastian Flores; Mingliang Jin; Kate Kim; Victor L Lam; Fei Li; Junrui Li; Yen-Li Li; Yang Li; Xi Liu; Megan Lo; Kyle E Lopez; Arthur A Melo; Frank R Moss; Phuong Nguyen; Joana Paulino; Komal Ishwar Pawar; Jessica K Peters; Thomas H Pospiech; Maliheh Safari; Smriti Sangwan; Kaitlin Schaefer; Paul V Thomas; Aye C Thwin; Raphael Trenker; Eric Tse; Tsz Kin Martin Tsui; Feng Wang; Natalie Whitis; Zanlin Yu; Kaihua Zhang; Yang Zhang; Fengbo Zhou; Daniel Saltzberg; Anthony J Hodder; Amber S Shun-Shion; Daniel M Williams; Kris M White; Romel Rosales; Thomas Kehrer; Lisa Miorin; Elena Moreno; Arvind H Patel; Suzannah Rihn; Mir M Khalid; Albert Vallejo-Gracia; Parinaz Fozouni; Camille R Simoneau; Theodore L Roth; David Wu; Mohd Anisul Karim; Maya Ghoussaini; Ian Dunham; Francesco Berardi; Sebastian Weigang; Maxime Chazal; Jisoo Park; James Logue; Marisa McGrath; Stuart Weston; Robert Haupt; C James Hastie; Matthew Elliott; Fiona Brown; Kerry A Burness; Elaine Reid; Mark Dorward; Clare Johnson; Stuart G Wilkinson; Anna Geyer; Daniel M Giesel; Carla Baillie; Samantha Raggett; Hannah Leech; Rachel Toth; Nicola Goodman; Kathleen C Keough; Abigail L Lind; Reyna J Klesh; Kafi R Hemphill; Jared Carlson-Stevermer; Jennifer Oki; Kevin Holden; Travis Maures; Katherine S Pollard; Andrej Sali; David A Agard; Yifan Cheng; James S Fraser; Adam Frost; Natalia Jura; Tanja Kortemme; Aashish Manglik; Daniel R Southworth; Robert M Stroud; Dario R Alessi; Paul Davies; Matthew B Frieman; Trey Ideker; Carmen Abate; Nolwenn Jouvenet; Georg Kochs; Brian Shoichet; Melanie Ott; Massimo Palmarini; Kevan M Shokat; Adolfo García-Sastre; Jeremy A Rassen; Robert Grosse; Oren S Rosenberg; Kliment A Verba; Christopher F Basler; Marco Vignuzzi; Andrew A Peden; Pedro Beltrao; Nevan J Krogan
Journal:  Science       Date:  2020-10-15       Impact factor: 47.728

10.  Recent Advances in the Development of Sigma Receptor Ligands as Cytotoxic Agents: A Medicinal Chemistry Perspective.

Authors:  Antonino N Fallica; Valeria Pittalà; Maria N Modica; Loredana Salerno; Giuseppe Romeo; Agostino Marrazzo; Mohamed A Helal; Sebastiano Intagliata
Journal:  J Med Chem       Date:  2021-06-02       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.